$1.18
0.00630.54%
Last update: 1:45 PM
15 minutes delayed
Comments
Loading...
Chromocell Therapeutics
CHROAMEX
Chromocell Therapeutics (AMEX:CHRO) Stock, Earnings Estimates, EPS, And Revenue
Chromocell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 15
EPS
$-0.550
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Chromocell Therapeutics using advanced sorting and filters.
Chromocell Therapeutics (CHRO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Chromocell Therapeutics (CHRO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Chromocell Therapeutics (AMEX:CHRO) reporting earnings?
Chromocell Therapeutics (CHRO) is scheduled to report earnings on August 20, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Chromocell Therapeutics (AMEX:CHRO)?
The Actual EPS was $-0.55, which missed the estimate of $0.00.
What were Chromocell Therapeutics’s (AMEX:CHRO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.